Risk factors associated with intracranial hemorrhage in neonates with persistent pulmonary hypertension on ECMO.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Journal titleJournal of intensive care
Publication Begin page6
MetadataShow full item record
AbstractBackground: Up to 40% of infants with persistent pulmonary hypertension (PPHN) remains refractory to conventional therapies, and extracorporeal membrane oxygenation (ECMO) is offered as an effective support for this group. However, ECMO is a highly invasive and risky procedure with devastating complications such as intracranial hemorrhage (ICH). In this study, we aimed to determine the risk factors for ICH in infants with PPHN. Methods: A case-control study of patients admitted to the pediatric intensive care unit (PICU) with PPHN requiring ECMO support was conducted. The study was carried out at a 25-bed PICU in large urban tertiary care children's hospital. A total number of 32 subjects were studied. Patients with and without ICH during ECMO were evaluated for activated clotting time (ACT), heparin dosing, platelet count, coagulation profile such as activated partial thromboplastin time (aPTT), prothrombin time (PT), international normalized ratio (INR), fibrinogen level, vital signs including heart rate and mean arterial pressure (MAP), transfusion history, gestational age, and severity of pre-ECMO illness as possible risk factors. Results: Low fibrinogen level (115 ± 13 mg/dl) and low platelet counts (37.4 ± 18.3 Thousand/μl) were associated with higher incidence of ICH (p = 0.009 and p = 0.005, respectively). Elevated MAP (69 ± 4.34 mmHg) was also noticed in ICH patients (p = 0.006). Conclusions: Results demonstrated that low fibrinogen level and low platelet count were associated with ICH in PPHN patients on ECMO. While on ECMO support, maintaining fibrinogen and platelet counts within normal ranges seems crucial to prevent ICH in PPHN patients. This is the first report identifying low fibrinogen level among the risk factors for ICH in infants with PPHN on ECMO support.
CitationDoymaz S, Zinger M, Sweberg T. Risk factors associated with intracranial hemorrhage in neonates with persistent pulmonary hypertension on ECMO. J Intensive Care. 2015 Feb 11;3(1):6. doi: 10.1186/s40560-015-0071-x. PMID: 25705431; PMCID: PMC4336126.
The following license files are associated with this item:
- Creative Commons
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 International
- Risk factors for intracranial hemorrhage in the extracorporeal membrane oxygenation patient.
- Authors: Dela Cruz TV, Stewart DL, Winston SJ, Weatherman KS, Phelps JL, Mendoza JC
- Issue date: 1997 Jan-Feb
- Hemorrhagic complications during extracorporeal membrane oxygenation: prevention and treatment.
- Authors: Sell LL, Cullen ML, Whittlesey GC, Yedlin ST, Philippart AI, Bedard MP, Klein MD
- Issue date: 1986 Dec
- Laboratory and clinical predictors of thrombosis and hemorrhage in 29 pediatric extracorporeal membrane oxygenation nonsurvivors.
- Authors: Reed RC, Rutledge JC
- Issue date: 2010 Sep-Oct
- Coagulation Profile Is Not a Predictor of Acute Cerebrovascular Events in Pediatric Extracorporeal Membrane Oxygenation Patients.
- Authors: Anton-Martin P, Journeycake J, Modem V, Golla S, Raman L, Tweed J, Darnell-Bowens C
- Issue date: 2017 Nov/Dec
- Hematological abnormalities in neonatal patients treated with extracorporeal membrane oxygenation (ECMO).
- Authors: Zavadil DP, Stammers AH, Willett LD, Deptula JJ, Christensen KA, Sydzyik RT
- Issue date: 1998 Jun